These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 33494369

  • 1. Pseudopeptide Amyloid Aggregation Inhibitors: In Silico, Single Molecule and Cell Viability Studies.
    Robinson M, Lou J, Mehrazma B, Rauk A, Beazely M, Leonenko Z.
    Int J Mol Sci; 2021 Jan 21; 22(3):. PubMed ID: 33494369
    [Abstract] [Full Text] [Related]

  • 2. Elucidating the inhibitory potential of Vitamin A against fibrillation and amyloid associated cytotoxicity.
    Alam P, Siddiqi MK, Malik S, Chaturvedi SK, Uddin M, Khan RH.
    Int J Biol Macromol; 2019 May 15; 129():333-338. PubMed ID: 30738899
    [Abstract] [Full Text] [Related]

  • 3. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K.
    Acc Chem Res; 2014 Aug 19; 47(8):2397-404. PubMed ID: 25029558
    [Abstract] [Full Text] [Related]

  • 4. Chemical and Physical Variability in Structural Isomers of an l/d α-Sheet Peptide Designed To Inhibit Amyloidogenesis.
    Maris NL, Shea D, Bleem A, Bryers JD, Daggett V.
    Biochemistry; 2018 Feb 06; 57(5):507-510. PubMed ID: 29202245
    [Abstract] [Full Text] [Related]

  • 5. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
    Zhang T, Gering I, Kutzsche J, Nagel-Steger L, Willbold D.
    ACS Chem Neurosci; 2019 Dec 18; 10(12):4800-4809. PubMed ID: 31710458
    [Abstract] [Full Text] [Related]

  • 6. Molecular Design for Dual Modulation Effect of Amyloid Protein Aggregation.
    Zhu L, Song Y, Cheng PN, Moore JS.
    J Am Chem Soc; 2015 Jul 01; 137(25):8062-8. PubMed ID: 26043045
    [Abstract] [Full Text] [Related]

  • 7. Curcumin Attenuates Amyloid-β Aggregate Toxicity and Modulates Amyloid-β Aggregation Pathway.
    Thapa A, Jett SD, Chi EY.
    ACS Chem Neurosci; 2016 Jan 20; 7(1):56-68. PubMed ID: 26529184
    [Abstract] [Full Text] [Related]

  • 8. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
    Du Z, Li M, Ren J, Qu X.
    Acc Chem Res; 2021 May 04; 54(9):2172-2184. PubMed ID: 33881820
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
    Sharma S, Nehru B, Saini A.
    Neurochem Int; 2017 Sep 04; 108():481-493. PubMed ID: 28652220
    [Abstract] [Full Text] [Related]

  • 10. Tanshinones inhibit amyloid aggregation by amyloid-β peptide, disaggregate amyloid fibrils, and protect cultured cells.
    Wang Q, Yu X, Patal K, Hu R, Chuang S, Zhang G, Zheng J.
    ACS Chem Neurosci; 2013 Jun 19; 4(6):1004-15. PubMed ID: 23506133
    [Abstract] [Full Text] [Related]

  • 11. Recent Progress in the Drug Development for the Treatment of Alzheimer's Disease Especially on Inhibition of Amyloid-peptide Aggregation.
    Liu Y, Cong L, Han C, Li B, Dai R.
    Mini Rev Med Chem; 2021 Jun 19; 21(8):969-990. PubMed ID: 33245270
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Aβ Amyloid Growth and Toxicity by Silybins: The Crucial Role of Stereochemistry.
    Sciacca MFM, Romanucci V, Zarrelli A, Monaco I, Lolicato F, Spinella N, Galati C, Grasso G, D'Urso L, Romeo M, Diomede L, Salmona M, Bongiorno C, Di Fabio G, La Rosa C, Milardi D.
    ACS Chem Neurosci; 2017 Aug 16; 8(8):1767-1778. PubMed ID: 28562008
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.
    Goyal D, Shuaib S, Mann S, Goyal B.
    ACS Comb Sci; 2017 Feb 13; 19(2):55-80. PubMed ID: 28045249
    [Abstract] [Full Text] [Related]

  • 15. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
    Goldblatt G, Cilenti L, Matos JO, Lee B, Ciaffone N, Wang QX, Tetard L, Teter K, Tatulian SA.
    FEBS J; 2017 May 13; 284(9):1355-1369. PubMed ID: 28294556
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer's disease.
    Khambete MP, Khare LP, Kapadia AB, Degani MS.
    Drug Metab Pers Ther; 2020 Aug 10; 35(3):. PubMed ID: 32776895
    [Abstract] [Full Text] [Related]

  • 18. Significant combination of Aβ aggregation inhibitory and neuroprotective properties in silico, in vitro and in vivo by bis(propyl)-cognitin, a multifunctional anti-Alzheimer's agent.
    Hu S, Xian Y, Fan Y, Mak S, Wang J, Tang J, Pang Y, Pi R, Tsim KW, Liu F, Lin Z, Han Y.
    Eur J Pharmacol; 2020 Jun 05; 876():173065. PubMed ID: 32171792
    [Abstract] [Full Text] [Related]

  • 19. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ42) and Chelation of Zinc Metal Ion.
    Asadbegi M, Shamloo A.
    ACS Chem Neurosci; 2019 Nov 20; 10(11):4619-4632. PubMed ID: 31566950
    [Abstract] [Full Text] [Related]

  • 20. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
    Klein AN, Ziehm T, van Groen T, Kadish I, Elfgen A, Tusche M, Thomaier M, Reiss K, Brener O, Gremer L, Kutzsche J, Willbold D.
    ACS Chem Neurosci; 2017 Sep 20; 8(9):1889-1900. PubMed ID: 28581708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.